{"id":17794,"date":"2013-09-06T17:17:58","date_gmt":"2013-09-07T00:17:58","guid":{"rendered":"http:\/\/drduru.com\/onetwentytwo\/?p=17794"},"modified":"2013-09-06T17:17:58","modified_gmt":"2013-09-07T00:17:58","slug":"for-marvell-technology-it-is-time-for-share-replacement-therapy","status":"publish","type":"post","link":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/","title":{"rendered":"For Marvell Technology, It Is Time for Share Replacement Therapy"},"content":{"rendered":"<p><strong>(This is an excerpt from an article I originally published on Seeking Alpha on May 7, 2013. <a href=\"http:\/\/seekingalpha.com\/article\/1408051-for-marvell-technology-it-is-time-for-share-replacement-therapy\" target=\"_blank\">Click here to read the entire piece<\/a>.)<\/strong><\/p>\n<p>Marvell Technology (MRVL) has enjoyed a tremendous run since hurtling downward after a legal setback in its patent dispute with Carnegie Mellon back in December. At the time, I thought it would consign MRVL to dead-money status until legal arguments resumed in May of this year (see &#8220;<a href=\"http:\/\/seekingalpha.com\/article\/1083451-loss-in-patent-case-turns-marvell-technology-into-dead-money\" target=\"_blank\">Loss in Patent Case Turns Marvell Technology Into Dead Money<\/a>&#8220;). Just one week later, I realized that the stock was exhibiting classic signs of printing a sustained bottom (see &#8220;<a href=\"http:\/\/drduru.com\/onetwentytwo\/2013\/01\/12\/stronger-signs-of-bottom-for-marvel\/\" target=\"_blank\">Chart Review: Stronger Signs Of A Bottom for Marvell Technology<\/a>&#8220;). A quick plunge and recovery in the stock on May 2nd as legal arguments resumed was a great reminder of how the patent infringement case may yet impact the stock. <\/p>\n<p><center><br \/>\n<figure id=\"attachment_17846\" aria-describedby=\"caption-attachment-17846\" style=\"width: 490px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png\" alt=\"MRVL hangs tough in the face of patent verdict and resumption of court arguments\" title=\"MRVL hangs tough in the face of patent verdict and resumption of court arguments\" width=\"500\" height=\"350\" class=\"size-full wp-image-17846\" srcset=\"https:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png 500w, https:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL-300x210.png 300w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/a><figcaption id=\"caption-attachment-17846\" class=\"wp-caption-text\">MRVL hangs tough in the face of patent verdict and resumption of court arguments<\/figcaption><\/figure><br \/>\n<strong>Source: <a href=\"http:\/\/www.freestockcharts.com\/\" target=\"_blank\">FreeStockCharts.com<\/a><\/strong><br \/>\n<\/center><\/p>\n<p>{snip}<\/p>\n<p>Regardless, I had May painted red in my calendar for MRVL, and on May 1st I decided it was time for some share replacement therapy to help me sleep at night through the final settlement of this case. On May 1st, <a href=\"https:\/\/twitter.com\/DrDuru\" target=\"_blank\">I tweeted<\/a> that call options looked exceptionally cheap.{snip}<\/p>\n<p>{snip}<\/p>\n<p>Even with these promising signs as backdrop, I executed the share replacement therapy. I promptly replaced my shares with January, 2014 call options. {snip}<\/p>\n<p>From the press reporting of the case, it seems that MRVL is planting its hopes on getting the judgment significantly reduced, if not eliminated. <\/p>\n<p>{snip}<\/p>\n<p>Be careful out there!<\/p>\n<p><strong>(This is an excerpt from an article I originally published on Seeking Alpha on May 7, 2013. <a href=\"http:\/\/seekingalpha.com\/article\/1408051-for-marvell-technology-it-is-time-for-share-replacement-therapy\" target=\"_blank\">Click here to read the entire piece<\/a>.)<\/strong><\/p>\n<p>Full disclosure: long MRVL call options.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(This is an excerpt from an article I originally published on Seeking Alpha on May 7, 2013. Click here to read the entire piece.) Marvell Technology (MRVL) has enjoyed a tremendous run since hurtling downward after a legal setback in its patent dispute with Carnegie Mellon back in December. At the time, I thought it &#8230; <a title=\"For Marvell Technology, It Is Time for Share Replacement Therapy\" class=\"read-more\" href=\"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[219],"tags":[1088,1087],"class_list":["post-17794","post","type-post","status-publish","format-standard","hentry","category-high-tech","tag-marvell-technology-group-ltd","tag-mrvl"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>For Marvell Technology, It Is Time for Share Replacement Therapy - ONE-TWENTY TWO: Trading Financial Markets<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"For Marvell Technology, It Is Time for Share Replacement Therapy - ONE-TWENTY TWO: Trading Financial Markets\" \/>\n<meta property=\"og:description\" content=\"(This is an excerpt from an article I originally published on Seeking Alpha on May 7, 2013. Click here to read the entire piece.) Marvell Technology (MRVL) has enjoyed a tremendous run since hurtling downward after a legal setback in its patent dispute with Carnegie Mellon back in December. At the time, I thought it ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"ONE-TWENTY TWO: Trading Financial Markets\" \/>\n<meta property=\"article:published_time\" content=\"2013-09-07T00:17:58+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png\" \/>\n<meta name=\"author\" content=\"Dr. Duru\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@drduru\" \/>\n<meta name=\"twitter:site\" content=\"@drduru\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Duru\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/\"},\"author\":{\"name\":\"Dr. Duru\",\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/#\\\/schema\\\/person\\\/d9569fde6c701b021a8d958f775be9a0\"},\"headline\":\"For Marvell Technology, It Is Time for Share Replacement Therapy\",\"datePublished\":\"2013-09-07T00:17:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/\"},\"wordCount\":305,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/#\\\/schema\\\/person\\\/d9569fde6c701b021a8d958f775be9a0\"},\"image\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/drduru.com\\\/onetwentytwo\\\/wp-content\\\/uploads\\\/2013\\\/05\\\/130506_MRVL.png\",\"keywords\":[\"Marvell Technology Group Ltd\",\"MRVL\"],\"articleSection\":[\"High Tech\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/\",\"url\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/\",\"name\":\"For Marvell Technology, It Is Time for Share Replacement Therapy - ONE-TWENTY TWO: Trading Financial Markets\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/drduru.com\\\/onetwentytwo\\\/wp-content\\\/uploads\\\/2013\\\/05\\\/130506_MRVL.png\",\"datePublished\":\"2013-09-07T00:17:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/#primaryimage\",\"url\":\"http:\\\/\\\/drduru.com\\\/onetwentytwo\\\/wp-content\\\/uploads\\\/2013\\\/05\\\/130506_MRVL.png\",\"contentUrl\":\"http:\\\/\\\/drduru.com\\\/onetwentytwo\\\/wp-content\\\/uploads\\\/2013\\\/05\\\/130506_MRVL.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/2013\\\/09\\\/06\\\/for-marvell-technology-it-is-time-for-share-replacement-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"For Marvell Technology, It Is Time for Share Replacement Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/#website\",\"url\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/\",\"name\":\"ONE-TWENTY TWO: Trading Financial Markets\",\"description\":\"Exploring the poetry in financial markets for students of money and economy since the year 2000.\",\"publisher\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/#\\\/schema\\\/person\\\/d9569fde6c701b021a8d958f775be9a0\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/#\\\/schema\\\/person\\\/d9569fde6c701b021a8d958f775be9a0\",\"name\":\"Dr. Duru\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/cropped-masthead-header.jpg\",\"url\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/cropped-masthead-header.jpg\",\"contentUrl\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/cropped-masthead-header.jpg\",\"width\":900,\"height\":100,\"caption\":\"Dr. Duru\"},\"logo\":{\"@id\":\"https:\\\/\\\/drduru.com\\\/onetwentytwo\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/cropped-masthead-header.jpg\"},\"sameAs\":[\"http:\\\/\\\/www.drduru.com\\\/onetwentytwo\",\"https:\\\/\\\/www.instagram.com\\\/drduru_market_breadth\\\/\",\"https:\\\/\\\/x.com\\\/drduru\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"For Marvell Technology, It Is Time for Share Replacement Therapy - ONE-TWENTY TWO: Trading Financial Markets","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/","og_locale":"en_US","og_type":"article","og_title":"For Marvell Technology, It Is Time for Share Replacement Therapy - ONE-TWENTY TWO: Trading Financial Markets","og_description":"(This is an excerpt from an article I originally published on Seeking Alpha on May 7, 2013. Click here to read the entire piece.) Marvell Technology (MRVL) has enjoyed a tremendous run since hurtling downward after a legal setback in its patent dispute with Carnegie Mellon back in December. At the time, I thought it ... Read more","og_url":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/","og_site_name":"ONE-TWENTY TWO: Trading Financial Markets","article_published_time":"2013-09-07T00:17:58+00:00","og_image":[{"url":"http:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png","type":"","width":"","height":""}],"author":"Dr. Duru","twitter_card":"summary_large_image","twitter_creator":"@drduru","twitter_site":"@drduru","twitter_misc":{"Written by":"Dr. Duru","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/#article","isPartOf":{"@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/"},"author":{"name":"Dr. Duru","@id":"https:\/\/drduru.com\/onetwentytwo\/#\/schema\/person\/d9569fde6c701b021a8d958f775be9a0"},"headline":"For Marvell Technology, It Is Time for Share Replacement Therapy","datePublished":"2013-09-07T00:17:58+00:00","mainEntityOfPage":{"@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/"},"wordCount":305,"commentCount":0,"publisher":{"@id":"https:\/\/drduru.com\/onetwentytwo\/#\/schema\/person\/d9569fde6c701b021a8d958f775be9a0"},"image":{"@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/#primaryimage"},"thumbnailUrl":"http:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png","keywords":["Marvell Technology Group Ltd","MRVL"],"articleSection":["High Tech"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/","url":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/","name":"For Marvell Technology, It Is Time for Share Replacement Therapy - ONE-TWENTY TWO: Trading Financial Markets","isPartOf":{"@id":"https:\/\/drduru.com\/onetwentytwo\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/#primaryimage"},"image":{"@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/#primaryimage"},"thumbnailUrl":"http:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png","datePublished":"2013-09-07T00:17:58+00:00","breadcrumb":{"@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/#primaryimage","url":"http:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png","contentUrl":"http:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2013\/05\/130506_MRVL.png"},{"@type":"BreadcrumbList","@id":"https:\/\/drduru.com\/onetwentytwo\/2013\/09\/06\/for-marvell-technology-it-is-time-for-share-replacement-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/drduru.com\/onetwentytwo\/"},{"@type":"ListItem","position":2,"name":"For Marvell Technology, It Is Time for Share Replacement Therapy"}]},{"@type":"WebSite","@id":"https:\/\/drduru.com\/onetwentytwo\/#website","url":"https:\/\/drduru.com\/onetwentytwo\/","name":"ONE-TWENTY TWO: Trading Financial Markets","description":"Exploring the poetry in financial markets for students of money and economy since the year 2000.","publisher":{"@id":"https:\/\/drduru.com\/onetwentytwo\/#\/schema\/person\/d9569fde6c701b021a8d958f775be9a0"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/drduru.com\/onetwentytwo\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/drduru.com\/onetwentytwo\/#\/schema\/person\/d9569fde6c701b021a8d958f775be9a0","name":"Dr. Duru","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2018\/09\/cropped-masthead-header.jpg","url":"https:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2018\/09\/cropped-masthead-header.jpg","contentUrl":"https:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2018\/09\/cropped-masthead-header.jpg","width":900,"height":100,"caption":"Dr. Duru"},"logo":{"@id":"https:\/\/drduru.com\/onetwentytwo\/wp-content\/uploads\/2018\/09\/cropped-masthead-header.jpg"},"sameAs":["http:\/\/www.drduru.com\/onetwentytwo","https:\/\/www.instagram.com\/drduru_market_breadth\/","https:\/\/x.com\/drduru"]}]}},"_links":{"self":[{"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/posts\/17794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/comments?post=17794"}],"version-history":[{"count":7,"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/posts\/17794\/revisions"}],"predecessor-version":[{"id":19672,"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/posts\/17794\/revisions\/19672"}],"wp:attachment":[{"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/media?parent=17794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/categories?post=17794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drduru.com\/onetwentytwo\/wp-json\/wp\/v2\/tags?post=17794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}